Linked Life Data

6178284

Source:http://linkedlifedata.com/resource/pubmed/id/6178284

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1982-8-26
pubmed:abstractText
Daily intramuscular injections of 3 X 10(6) international units of human leukocyte interferon were given to five patients with advanced ovarian carcinoma, all of whom previously received other forms of treatment. Ascitic fluid production ceases in two out of two patients. According to the criteria specified by Young and DeVita a partial response was observed in one patient and in two other patients the disease was stable for more than 1 year. Side effects of the interferon therapy were relatively mild. The introduction of interferon therapy was followed by an increase in the natural killer cell activity of peripheral blood lymphocytes in all three patients examined. Natural killer cell activity decreased after cessation of interferon therapy in the one patient where this was tested.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0277-3732
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
167-72
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed:year
1982
pubmed:articleTitle
Human leukocyte interferon therapy for advanced ovarian carcinoma.
pubmed:publicationType
Journal Article, Comparative Study, Case Reports, Research Support, Non-U.S. Gov't